Macleods Pharmaceutical Limited recalls Macleods — Losartan Potassium USP tablets and Losartan Potassium/Hydrochlorothiazide combination ta…
- Recall date
- June 26, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Macleods Pharmaceutical Limited, Macleods
Why it was recalled
Presence of NMBA impurity — Unapproved Ingredient
What was recalled
Losartan Potassium USP tablets and Losartan Potassium/Hydrochlorothiazide combination tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Macleods Pharmaceutical Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Macleods Pharmaceutical Limited, Macleods